Treatment of Methotrexate-Induced Oral Mucositis
For methotrexate-induced oral mucositis, immediately discontinue methotrexate, initiate folic acid supplementation (1-5 mg daily), and implement a comprehensive oral hygiene protocol with alcohol-free mouth rinses four times daily. 1, 2, 3
Immediate Management Steps
1. Stop Methotrexate and Assess Severity
- Discontinue methotrexate immediately when oral mucositis develops 4, 5
- Evaluate for systemic toxicity (pancytopenia, transaminitis) as oral lesions may signal broader methotrexate toxicity 6, 7
- Consider hospitalization if severe mucositis is present or if systemic signs of toxicity exist 8, 4
2. Folate Rescue Therapy
- Start folic acid 1-5 mg daily (or increase dose if already on supplementation) 1, 2, 3
- For severe toxicity with systemic involvement, administer leucovorin calcium (folinic acid) rescue therapy intravenously 6, 7
- Folic acid supplementation reduces gastrointestinal and oral toxicity without compromising methotrexate efficacy 9
3. Oral Hygiene Protocol
Implement the following basic oral care regimen 10:
Daily oral care:
- Brush teeth and gums four times daily with a soft toothbrush
- Use alcohol-free mouthwash at least four times daily for 1 minute (15 mL), particularly after brushing
- Inspect oral mucosa daily for progression
- Keep mouth moist with adequate fluid intake
- Apply lip lubricant (avoid chronic petroleum jelly use due to infection risk)
Avoid irritants:
- No smoking or alcohol
- Avoid citrus fruits, tomatoes, hot/spicy foods, and crusty foods
- Remove ill-fitting dentures until healing occurs
4. Pain Management
First-line: Magic mouthwash (combination topical anesthetic solution) 8
If inadequate response after 24 hours: Switch to morphine mouthwash solution 8
- Morphine mouthwash provides superior pain control compared to magic mouthwash in refractory cases
- Safer than systemic opioids
- May promote healing through effects on cell proliferation and migration
- Typical duration: 6 days with monitoring for lesion improvement
Alternative: Topical anesthetics can provide short-term relief on an empiric basis 10
Prevention Strategies for Future Use
Route and Dosing Modifications
If methotrexate must be restarted after resolution 1, 11, 1:
For intolerance to oral methotrexate:
- Switch to subcutaneous or intramuscular administration (reduces GI and oral side effects) 1, 11, 1
- Consider split dosing over 24 hours (three divided doses every 12 hours) 1, 3, 11
- Increase folic acid dose to 5 mg daily (given daily except on methotrexate day) 2, 3
Mandatory Folic Acid Supplementation
- All patients on methotrexate should receive folic acid 1-5 mg daily (except on methotrexate administration day) 2, 3, 12
- This reduces oral mucositis, nausea, and hepatotoxicity without reducing efficacy 9
Common Pitfalls to Avoid
- Dosing errors: Methotrexate is dosed weekly, not daily - daily administration causes severe toxicity including mucositis within 3-6 days 5, 13
- Missing folic acid: Non-compliance with folic acid supplementation significantly increases mucositis risk 8, 4
- Delayed recognition: Oral mucositis may be the first sign of systemic methotrexate toxicity requiring immediate intervention 6, 4
- Drug interactions: NSAIDs, trimethoprim-sulfamethoxazole, and other medications can increase methotrexate toxicity 12, 5
- Renal dysfunction: Impaired renal function increases toxicity risk - avoid methotrexate if creatinine clearance <20 mL/min 12
When to Refer or Hospitalize
Consider hospitalization for 8, 6, 4:
- Severe mucositis preventing oral intake
- Signs of systemic toxicity (pancytopenia, transaminitis)
- Need for leucovorin rescue therapy
- Elderly or frail patients with any toxicity (higher mortality risk) 7